Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;29(8):953-60.
doi: 10.1007/s00384-014-1915-x. Epub 2014 Jun 10.

Risk of comorbidities and outcomes in patients with lower gastrointestinal bleeding - a nationwide study

Affiliations

Risk of comorbidities and outcomes in patients with lower gastrointestinal bleeding - a nationwide study

Preethi G K Venkatesh et al. Int J Colorectal Dis. 2014 Aug.

Abstract

Background: The impact of comorbidities on outcomes of patients with lower gastrointestinal bleeding (LGIB) remains unknown.

Objective: Investigate the prevalence of comorbidities and impact on outcomes of patients with LGIB.

Methods: The Nationwide Inpatient Sample 2010 was used to identify patients who had a primary discharge diagnosis of LGIB based on International Classification of Diseases, the 9th revision, clinical modification codes. The presence of comorbid illness was assessed using the Elixhauser index. Logistic regression models were used to assess the contributions of the individual Elixhauser comorbidities to predict in-hospital mortality.

Results: A total of 58,296 discharges with LGIB were identified. The overall mortality was 2.3 %. Among the patients who underwent colonoscopy, 17.3 % of patients had therapeutic intervention. As the number of comorbidities increased (i.e., 0, 1, 2, or >3), mortality increased (1.7, 2.0, 2.4, and 2.4 %, respectively). The mortality rate was highest in patients >65 years of age (2.7 %). Patients >65 years of age with two or more comorbidities had a mortality rate of 5 % as compared to 2.6 % in those with less than two comorbidities. Congestive heart failure (odds ratio, 1.67 [95 % confidence interval, 1.48-1.95]), liver disease (2.64 [1.83-3.80]), renal failure (1.99 [1.70-2.33]), and weight loss (2.66 [2.27-3.12]) were associated with a significant increase in mortality rate. Comorbidities increased hospital stay and costs.

Conclusions: Comorbidities were associated with increased the risk of mortality and health care utilization in patients with LGIB. Identification of comorbidities and development of risk-adjustment tools may improve the outcome of patients with LGIB.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declared no financial conflict of interest.

Figures

Fig. 1
Fig. 1
Probability of death for Patients with Lower Gastrointestinal Bleeding stratified by age, and number of comorbidities. Patients > 65 years of age with 2 or more comorbidities had a mortality rate of 5 % as compared to 2.6 % in those with less than 2 comorbidities

References

    1. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104:1633–1641. - PubMed
    1. Leontiadis GI, Molloy-Bland M, Moayyedi P, Howden CW. Effect of comorbidity on mortality in patients with peptic ulcer bleeding: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(3):331–345. - PubMed
    1. Parasa S, Navaneethan U, Sridhar AR, Venkatesh PG, Olden K. End-stage renal disease is associated with worse outcomes in hospitalized patients with peptic ulcer bleeding. Gastrointest Endosc. 2013;77(4):609–616. - PubMed
    1. Venkatesh PG, Parasa S, Njei B, Sanaka M, Navaneethan U. Increased mortality with peptic ulcer bleeding in patients with both compensated and decompensated cirrhosis. Gastrointest Endosc. 2013 doi: 10.1016/j.gie.2013.08.026. - DOI - PubMed
    1. Strate LL, Ayanian JZ, Kotler G, Syngal S. Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol. 2008;6(9):1004–1010. - PMC - PubMed

Publication types